Post-Conference Perspectives: Updates on TIL Therapy for Solid Tumors, Including Melanoma and NSCLC
Expert perspectives from Amod Sarnaik, MD, and Krishna Komanduri, MD, on the evolving role of tumor-infiltrating lymphocyte therapy in solid tumors, following the Society for Immunotherapy of Cancer (SITC) 2022 meeting.
Emerging CAR-T Therapies in Large B-cell Lymphomas (LBCL): Highlights from ASH 2022 and Beyond
Experts review key updates in LBCL management from the ASH 2022 annual meeting.
2 Clarke Drive Cranbury, NJ 08512